Aktuellt
Petersén’s talk at RHS meeting 2025
2025-12-18The Swedish patients' organisation, RHS, held their yearly meeting in October 2025 and Professor Åsa Petersén was invited speaker. Petersén's talk addressed early symptoms in HD connected to research. The meeting was recorded and the films are now available on RHS' website. Link to the content at RHS' website - in Swedish only (opens in a new window)
Läs mer
Petersén gives talk at Scottish Huntington’s Association Meeting
2025-11-07Petersén is invited to give a talk at the 2025 Family Gathering for the Scottish Huntington's Association with around 170 attendees on November 8, 2025 in Glasgow. Link to the programme at the association’s webpage (opens in a new window)
Läs mer
TV4 news piece on HD gene therapy trial
2025-10-08The Swedish channel TV4 published the news on the HD clinical trials that were positively described in media in late September. Professor Åsa Petersén was interviewed about the findings by TV4 and she emphasizes the need for cautiousness when interpreting the results, as they are not yet published in a scientific magazine or reviewed by researchers not involved in the study. Link to the article on TV4:s webpage - in Swedish only (opens in a…
Läs mer
Professor Petersén comments on the recent positive topline results from a clinical trial with gene therapy in Huntington disease presented in a press release from uniQure
2025-09-30Last week, positive topline results from a clinical trial with gene therapy in Huntington disease were presented in a press release from uniQure. The news hit the headlines and spread fast through the HD community. Read Professor Petersén's comments on these results in plain language for the wider audience in The Conversation and in a statement as deputy chair for the European HD Network. Link to the The Conversation's website (opens in a new window)…
Läs mer
Updated information on Huntington disease on the National Board of Health and Welfare’s webpage
2025-09-24The National Board of Health and Welfare in Sweden has published updated information on Huntington disease on its' webpage. These recent revisions of the text have been made by Professor Åsa Petersén, Lund University. Link to the National Board of Health and Welfare's webpage - in Swedish only (opens in a new window).
Läs mer
Petersén at the EHA conference 2025 in Bucharest
2025-09-23Åsa Petersén will give several talks at the EHA conference, including one on emotions and behavior in HD, and she will also chair a session on clinical trials. The conference is arranged by the patients' organization, the European Huntington Association, and is open to all. Find out more about the conference on EHA:s webpage (opens in a new window).
Läs mer
Visit by the European Huntington Association
2025-09-03When in Sweden for their annual meeting, members of the European Huntington Association paid a visit to Lund on 28 August 2025. There they met with Åsa Petersén and Camilla Svensson, registered nurse, also working at the HD Clinic at Skåne University Hospital (SUS) in Lund, together with Åsa. Åsa showed them around the lab, demonstrated samples and talked about her research. The EHA team also got to know about the multidisciplinary team at the…
Läs mer
Petersén gives a talk at a symposium on neurodegenerative disorders in Vancouver, Canada
2025-09-01Petersén will give a talk on her work on Huntington disease at a symposium on neurodegenerative disorders at the University of British Columbia in Vancouver, Canada on September 8, 2025. There will also be a meeting for Petersén and other partners in the JPND funded delCAA-HD research team to discuss progress of the international collaborative research efforts.
Läs mer
New article on HD published by TNU
2025-06-04TDP-43 is a protein involved i several severe brain disorders. Recently an increasing number of researcher have begun to investigate how the TDP-43 might be involved in Huntington disease (HD). Åsa Petersén's research group, Translational Neuroendocrine Research Unit (TNU), have now published a scientific article studying the effects of TDP-43 in the brain's hormone central, hypothalamus, which is affected in HD. Read more on the MultiPark website (opens in a new window).
Läs mer
Podcast about being a young relative of an HD-patient
2025-05-22The month of May is Huntington’s Disease Awareness Month and 15 May was Huntington Awareness Day. Åsa Petersén was invited to take part in a podcast about the disease, together with Jozefine, who is a carrier of the gene and related to a person diagnosed with HD. The podcast is produced by YTAN, Young Together Against Neurodegenerative Diseases, a digital platform for young relatives of persons with a neurodegenerativ disease. YTAN is financed through a…
Läs mer